👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

Microsoft's EVP sells $1.5 million in stock

Published 03/12/2024, 10:06 am
© Reuters.
MSFT
-

Takeshi Numoto, Executive Vice President and Chief Marketing Officer at Microsoft Corp (NASDAQ:MSFT), recently sold a significant portion of his holdings in the company. The tech giant, currently valued at $3.2 trillion, maintains a "GREAT" financial health score according to InvestingPro analysis. According to a filing with the Securities and Exchange Commission, Numoto sold a total of 3,500 shares of Microsoft common stock. The transactions, which were executed on November 27 and December 2, 2024, were carried out at prices ranging from $423.48 to $430.873 per share, amounting to a total value of approximately $1.5 million. The stock currently trades near its 52-week high of $468.35, with InvestingPro analysis indicating the stock is fairly valued. Subscribers can access 15+ additional ProTips and comprehensive valuation metrics.

Following these sales, Numoto retains ownership of 53,851.8545 shares of Microsoft stock. Additionally, a separate transaction involved the disposition of 158.74 shares at a price of $423.46 per share, totaling $67,220. This activity reflects Numoto's continued management of his equity position in the company, which has maintained dividend payments for 22 consecutive years with a 10.67% dividend growth rate over the last twelve months.

In other recent news, Microsoft Corporation (NASDAQ:MSFT) continues to make significant strides in its AI and cloud sectors, with TD Cowen, Citi, Mizuho (NYSE:MFG), and Goldman Sachs (NYSE:GS) maintaining positive ratings on Microsoft's stock. The company reported a notable 16% year-on-year increase in Q1 FY2025 revenue to $65.6 billion, and its cloud unit, Microsoft Cloud, also reported robust performance, with revenues surpassing $38.9 billion, marking a 22% increase from the previous year.

Analysts expect Microsoft's AI business to exceed a $10 billion annual run rate in the upcoming quarter, reflecting the company's strong position in the AI technology realm. Microsoft's Ignite conference showcased over 80 new products and features, emphasizing customizable 'agents' tailored to different business units.

In the healthcare sector, Tevogen Bio has partnered with Microsoft to expedite the target identification process for their oncology product, TVGN 920, using AI and cloud technologies. In corporate developments, Asterion Industrial Partners, in collaboration with Telefonica (NYSE:TEF), sold Nabiax, a Spanish data center operator, to Aermont Capital. These are recent developments concerning Microsoft Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.